Pancreatic Cancer Research

ResearcherYokohama City UniversityActive in the last 2 years

Yuto Kamioka

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5049759509. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 3 papers · 2024: 3 papers · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. Tissue Factor as a Prognostic and Therapeutic Biomarker in Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-19380-z↗
  2. Overexpression of Nuclear Factor of Activated T-cells (NFAT) Transcription Factors Drives Chemoresistance and Poor Outcomes in Pancreatic Cancer. Co-author DOI 10.1245/s10434-025-18186-9↗
  3. Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant… Co-author DOI 10.1186/s12885-024-13244-z↗
  4. Clinical Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgical Patients With Pancreatic Cancer. Co-author DOI 10.21873/anticanres.16805↗
  5. Clinical Impact of Preoperative Prognostic Nutritional Index in Surgical Patients With Pancreatic Cancer Treated With Perioperative Adjuvant Chemotherapy. Co-author DOI 10.21873/anticanres.16970↗
  6. Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection. Co-author DOI 10.1186/s12957-023-03141-3↗
  7. Carbon Ion Radiotherapy Versus Perioperative Adjuvant Chemotherapy and Curative Surgery for Resectable Pancreatic Cancer. Co-author DOI 10.21873/anticanres.16222↗
  8. Incidence and Risk of Venous Thromboembolism in Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy. Co-author DOI 10.21873/anticanres.16327↗
  9. Postoperative acute pancreatitis after pancreatic resection in patients with pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00423-022-02481-0↗
  10. Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-insti… Co-author DOI 10.21873/invivo.11780↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masaaki Murakawa · 10 shared papers, 2020–2026 · strength 1.69
  2. Makoto Ueno · 10 shared papers, 2020–2026 · strength 1.69
  3. Soichiro Morinaga · 10 shared papers, 2020–2026 · strength 1.69
  4. Shinnosuke Kawahara · 9 shared papers, 2022–2026 · strength 1.59
  5. Naoto Yamamoto · 9 shared papers, 2020–2025 · strength 1.45
  6. Satoshi Kobayashi · 6 shared papers, 2020–2026 · strength 1.03
  7. Mariko Kamiya · 4 shared papers, 2020–2026 · strength 0.66
  8. Toru Aoyama · 4 shared papers, 2020–2025 · strength 0.63
  9. Hiroshi Tamagawa · 4 shared papers, 2020–2024 · strength 0.55
  10. Takashi Oshima · 3 shared papers, 2023–2024 · strength 0.52
  11. Kota Washimi · 2 shared papers, 2025–2026 · strength 0.44
  12. Yohei Miyagi · 2 shared papers, 2025–2026 · strength 0.44
  13. Manabu Morimoto · 3 shared papers, 2020–2023 · strength 0.39
  14. Toru Aoyama · 2 shared papers, 2023–2024 · strength 0.34
  15. Shiro Koizume · 1 shared paper, 2026 · strength 0.24
  16. Yukihiko Hiroshima · 1 shared paper, 2025 · strength 0.20
  17. Robert M. Hoffman · 1 shared paper, 2025 · strength 0.20
  18. Hiroyuki Katoh · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.